Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Parallel imports and innovation in an emerging economy: the case of Indian pharmaceuticals.
Health Econ
November 2012
Department of Economics, University of Bologna, Bologna, Italy.
This paper studies the impact of the re-importation of imitated pharmaceuticals as a by-product of an open policy toward parallel import (PI) on process innovation. Foreign investment by a firm to exploit a new unregulated market with weak intellectual property rights can give rise to imitation. These products can potentially re-enter the original country when PI is allowed influencing research and development (R&D) incentives.
View Article and Find Full Text PDFDoes reimportation reduce price differences for prescription drugs? Lessons from the European Union.
Health Serv Res
August 2008
The Fucqua School of Business, Duke University, Durham, NC, USA.
Objective: To examine the effect of parallel trade on patterns of price dispersion for prescription drugs in the European Union.
Data Sources: Longitudinal data from an IMS Midas database of prices and units sold for drugs in 36 categories in 30 countries from 1993 through 2004.
Study Design: The main outcome measures were mean price differentials and other measures of price dispersion within European Union countries compared with within non-European Union countries.
United States prescription drug crisis. Reimportation of Canadian prescription drugs is not the answer.
J Leg Med
December 2006
Southern Illinois University School of Law, c/o Law Journal Office, Carbondale, Illinois 62901, USA.
The role of bioethics in the international prescription drug market: economics and global justice.
Penn Bioeth J
December 2006
In terms of health care access, bioethics has an important role to inform and shape policy issues and develop interdisciplinary ideas and interventions. The rising price of prescription drugs presents one of the most looming barriers to health care access in the world today. Including both theoretical and practical features of the pharmaceutical industry's behavior is necessary to find ethical solutions towards increasing access.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!